OQRO

Pamela Ann Connealy

Pamela Ann Connealy's open-market purchases and sales year by year since 2006, and every transaction reported to the SEC on Form 4: date, shares, price and a…

Insider buying and selling since 2023

Pamela Ann Connealy bought shares on the open market in 2023 and 2024, and has not bought since 2024.

Pamela Ann Connealy reported 6 open-market purchases and 0 sales since 2023; purchases in 2 different years, most recently 2024.

YearBoughtSold
2024
2×
—
2023
4×
—

Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.

Trades disclosed

Latest trade

Largest trade

Companies

Every disclosed trade

CompanyActionValue
OQRO

Every trade this person has disclosed

Newest first, each one linked to the filing it came from.

Unlock OQRO Pro

Already a member? Sign in

What this page holds

  • Every disclosed trade, newest first
  • How purchases did after they were reported
  • Companies and committees involved
  • A link to every official filing

What OQRO is

OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.

Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.

Questions about Pamela Ann Connealy's trades

Has Pamela Ann Connealy bought shares on the open market?

Pamela Ann Connealy bought shares on the open market in 2023 and 2024, and has not bought since 2024.

When did Pamela Ann Connealy last buy or sell shares?

In SEC filings since 2023: the latest open-market purchase is from 2024; no open-market sale is on record.

Which companies has Pamela Ann Connealy traded as an insider?

Pyxis Oncology (PYXS), from 2023 to 2024: 6 purchases and 0 sales.

What this filing is, free to read